Trial Profile
A pragmatic multi-centre randomised controlled non-inferiority, cost effectiveness trial comparing injections of collagenase into the cord to surgical correction in the treatment of moderate Dupuytren's Contracture in adult patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2023
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Dupuytren's contracture
- Focus Therapeutic Use
- Acronyms DISC
- 01 Aug 2022 Status changed from active, no longer recruiting to completed.
- 19 Oct 2021 Planned End Date changed from 31 Oct 2021 to 31 Jul 2022.
- 19 Oct 2021 The protocol of study has beed amended because the withdrawal of marketing authorisation for the study intervention (collagenase), resulting in limited availability within the UK, the randomisation sequence was amended, with effect from the 21st of January 2020, to include stratification by the centre.